Reviva Pharmaceuticals Holdings's total assets for Q1 2026 were $23.56M, an increase of 47.96% from the previous quarter. RVPH total liabilities were $6.12M for the fiscal quarter, a -15.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.